97 related articles for article (PubMed ID: 9597380)
1. Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period.
García-Estévez DA; Araújo-Vilar D; Cabezas-Cerrato J
Diabetes Res Clin Pract; 1998 Feb; 39(2):107-13. PubMed ID: 9597380
[TBL] [Abstract][Full Text] [Related]
2. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
Page R; Boolell M; Kalfas A; Sawyer S; Pestell R; Ward G; Alford F
Clin Endocrinol (Oxf); 1991 Dec; 35(6):509-17. PubMed ID: 1769133
[TBL] [Abstract][Full Text] [Related]
3. Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects.
Baron AD; Kolterman OG; Bell J; Mandarino LJ; Olefsky JM
J Clin Invest; 1985 Nov; 76(5):1782-8. PubMed ID: 2865274
[TBL] [Abstract][Full Text] [Related]
4. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes.
Forbes A; Elliott T; Tildesley H; Finegood D; Meneilly GS
Diabetes; 1998 Dec; 47(12):1915-9. PubMed ID: 9836524
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism in lean patients with mild type 2 diabetes mellitus: evidence for insulin-sensitive and insulin-resistant variants.
García-Estévez DA; Araújo-Vilar D; Saavedra-González A; Fiestras-Janeiro G; Cabezas-Cerrato J
Metabolism; 2002 Aug; 51(8):1047-52. PubMed ID: 12145780
[TBL] [Abstract][Full Text] [Related]
6. Rates and tissue sites of noninsulin- and insulin-mediated glucose uptake in diabetic rats.
Lang CH
Proc Soc Exp Biol Med; 1992 Jan; 199(1):81-7. PubMed ID: 1728041
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
8. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
[TBL] [Abstract][Full Text] [Related]
9. Insulin action and hepatic glucose cycling in Cushing's syndrome.
Heaney AP; Harper R; Ennis C; Rooney DP; Sheridan B; Atkinson AB; Bell PM
Clin Endocrinol (Oxf); 1997 Jun; 46(6):735-43. PubMed ID: 9274705
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
[TBL] [Abstract][Full Text] [Related]
12. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
Walters JM; Ward GM; Barton J; Arackal R; Boston RC; Best JD; Alford FP
Metabolism; 1997 Dec; 46(12):1448-53. PubMed ID: 9439541
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
Campbell PJ; Mandarino LJ; Gerich JE
Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
[TBL] [Abstract][Full Text] [Related]
14. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
15. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.
Laakso M; Edelman SV; Brechtel G; Baron AD
Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861
[TBL] [Abstract][Full Text] [Related]
16. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
[TBL] [Abstract][Full Text] [Related]
17. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in Cushing's syndrome.
Karnieli E; Cohen P; Barzilai N; Ish-Shalom Z; Armoni M; Rafaelov R; Barzilai D
Horm Metab Res; 1985 Oct; 17(10):518-21. PubMed ID: 3905556
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states.
Scelles V; Raccah D; Alessi MC; Vialle JM; Juhan-Vague I; Vague P
Diabete Metab; 1992; 18(1):38-42. PubMed ID: 1563535
[TBL] [Abstract][Full Text] [Related]
20. NIDDM in the elderly.
Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
